Berotralstat
CAS 1809010-50-1Small Molecule
Overview
Berotralstat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL5189739).
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Berotralstat expires 1 May 2040 and exclusivity 11 Jun 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-[3-(aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)-(cyclopropylmethylamino)methyl]-2-fluorophenyl]-3-(trifluoromethyl)pyrazole-5-carboxamide
- Canonical SMILES
- C1CC1CN[C@@H](C2=CC(=C(C=C2)F)NC(=O)C3=CC(=NN3C4=CC=CC(=C4)CN)C(F)(F)F)C5=CC=CC(=C5)C#N
- InChIKey
- UXNXMBYCBRBRFD-MUUNZHRXSA-N
Verified Supplier Partner
Do you supply Berotralstat? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.